These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Immunosuppressive therapy of vasculitis: current aspects and perspectives]. Giacomelli R; Pizzuto F; Cucinelli F; Tonietti G Recenti Prog Med; 1996 Mar; 87(3):124-34. PubMed ID: 8650433 [TBL] [Abstract][Full Text] [Related]
28. Successful treatment of long-standing neuro-Behçet's disease with infliximab. Sarwar H; McGrath H; Espinoza LR J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746 [TBL] [Abstract][Full Text] [Related]
29. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Sweiss NJ; Curran J; Baughman RP Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312 [TBL] [Abstract][Full Text] [Related]
30. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade. Alty JE; Monaghan TM; Bamford JM Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468 [TBL] [Abstract][Full Text] [Related]
31. [Anatomopathology of inflammatory arteriopathies. Peculiar aspects of giant cell arteritis]. Chomette G; Auriol M; Tranbaloc P Ann Med Interne (Paris); 1983; 134(5):421-7. PubMed ID: 6139972 [TBL] [Abstract][Full Text] [Related]
33. The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide. Oharaseki T; Yokouchi Y; Yamada H; Mamada H; Muto S; Sadamoto K; Miura N; Ohno N; Saji T; Naoe S; Takahashi K Mod Rheumatol; 2014 Jan; 24(1):120-8. PubMed ID: 24261768 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic update in large vessel vasculitides. Pérez-Esteban S; González-Gay MA; Castañeda S Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962 [TBL] [Abstract][Full Text] [Related]
35. Giant cell and Takayasu arteritis. Seko Y Curr Opin Rheumatol; 2007 Jan; 19(1):39-43. PubMed ID: 17143094 [TBL] [Abstract][Full Text] [Related]
36. Treatment and outcomes of large vessel arteritis. Borg FA; Dasgupta B Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):325-37. PubMed ID: 19508941 [TBL] [Abstract][Full Text] [Related]
37. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964 [TBL] [Abstract][Full Text] [Related]
38. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group. Lamprecht P; Gross WL Arthritis Rheum; 2004 Jan; 50(1):334-5; author reply 335-6. PubMed ID: 14730635 [No Abstract] [Full Text] [Related]
39. Therapy of neurological disorders in systemic vasculitis. Gold R; Fontana A; Zierz S Semin Neurol; 2003 Jun; 23(2):207-14. PubMed ID: 12894386 [TBL] [Abstract][Full Text] [Related]